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 Removal of the chlorinated methanes, carbon tetrachloride (CT), chloroform (CF) 
and dichloromethane (DCM), and the halogenated methane, trichlorofluoromethane 
(commonly known as CFC-11 or Freon-11) from contaminated soil and groundwater 
remains challenging.  Releases to the environment resulted from historically poor 
disposal practices, as well as spills and leaks from underground storage tanks. Among 
these three compounds, CF is considered the benchmark for evaluating the feasibility of 
bioremediation, due to its typically high level of toxicity towards most anaerobic 
prokaryotes. However, inhibitory effects of low concentrations of CFC-11 on anaerobes 
have been reported as well. Bioremediation is an attractive option for clean-up, but 
requires developments in the technology, especially when the concentrations present are 
in the tens or hundreds of milligrams per liter. The focus of this thesis is on developing 
improved methods to bioremediate high concentrations of CFC-11, CF, and DCM.  In 
particular, the research focused on further characterizing two enrichment cultures 
previously developed at Clemson University. The DHM-1 enrichment culture 
cometabolically degrades high concentrations of CT, CF and CFC-11 with corn syrup as 
the electron donor and vitamin B12 as an essential cofactor. The DCM enrichment culture 
uses DCM as its sole source of carbon and energy via fermentation, releasing formate and 
acetate as major products. 
 The objectives of this research were 1) to determine a mass balance for fluoride 
release during biodegradation of CFC-11 by DHM-1, in the presence of corn syrup and 
B12; 2) to evaluate the effect of the dose of DHM-1 on the rate biodegradation of 500 
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mg/L of CF; 3) to evaluate the tolerance of the Clemson DCM enrichment culture to 
DCM concentrations greater than 500 mg/L; 4) to determine the effect of CF on DCM 
biodegradation by Clemson’s DCM enrichment culture, including the potential for 
acclimation to increasing concentrations of CF; 5) to confirm the accumulation of 
hydrogen during DCM biodegradation by Clemson’s DCM enrichment culture; 6) to 
evaluate the effect of hydrogen concentration on DCM biodegradation by Clemson’s 
DCM enrichment culture; and 7) to further characterize the identity of the microbe 
responsible for DCM biodegradation by Clemson’s DCM enrichment culture.   
 Experiments performed with the DHM-1 enrichment culture proved that in the 
presence of corn syrup and vitamin B12, the culture completely biodegraded 26 mg/L of 
CFC-11.  On a molar basis, less than 6% of the CFC-11 consumed accumulated as 
dichlorofluoromethane (HCFC-21) and chlorofluoromethane (HCFC-31).  The balance of 
the CFC-11 was defluorinated, based on stoichiometric release of fluoride.  These results 
confirm the ability of the DHM-1 enrichment culture to convert high concentrations of 
CFC-11 into nonhazardous products.  This result is consistent with previous research that 
demonstrates the same ability of DHM-1 with CT and CF.  The DHM-1 enrichment 
culture was also able to biodegrade approximately 500 mg/L of CF when the inoculum 
dose was as low as 10
-8
 percent by volume. These results demonstrate the potential to use 
the culture for bioaugmentation of source areas, since the dose required is minor relative 
to the volume of groundwater that could be treated. 
 Experiments performed with the DCM enrichment culture demonstrated an ability  
to biodegrade at least 740 mg/L of DCM, indicating its potential usefulness in treating 
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groundwater located near source areas containing dense, nonaqueous phase liquid 
(DNAPL). The addition of up to 6% H2 (by volume) to the headspace did not affect the 
degradation of DCM. With experiments designed to analyze the effect of CF on DCM 
degradation, addition of 1 mg/L of CF to the enrichment culture completely inhibited 
DCM biodegradation.  CF concentrations of 0.1 to 0.8 mg/L slowed the rate of DCM 
utilization but did not prevent it.  Preliminary efforts suggest it will be possible to 
gradually acclimate the DCM enrichment culture to CF concentrations above 1 mg/L.  
Efforts to isolate the DCM degrading microbe from this culture by sequential dilution in 
agar did not yield a pure culture; however, the process narrowed down the microbial 
community and facilitated better microscopic observation.  The dominant morphology 
consisted of gram positive thick rods, thin rods and filaments. The rods were similar in 
appearance and gram stain to Dehalobacterium, one of two genera known to grow on 
DCM as a sole carbon and energy source via fermentation. 
 The results of this study provide definitive evidence in support of the ability of the 
DHM-1 enrichment culture to degrade CFC-11 to non-hazardous end products, and 
degrade high concentrations of CF with a volumetric inoculum dose as low as 10
-8
%. 
Characterization of the DCM enrichment culture proved its ability to degrade high DCM 
concentrations. Even though 1 mg/L of CF inhibited DCM degradation, preliminary 
experiments set up to acclimate the culture to CF concentrations above 1 mg/L have 
shown promise. In order to identify the microbe that grows on DCM, additional effort is 
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CHAPTER ONE: INTRODUCTION AND OBJECTIVES 
 Halogenated methanes have been in widespread use worldwide for decades.  This 
includes the chlorinated methanes, carbon tetrachloride (CT), chloroform (CF) and 
dichloromethane (DCM), and the halogenated methane, trichlorofluoromethane 
(commonly known as CFC-11 or Freon-11). CT and CF have been used for a myriad of 
applications including dry cleaning, production of pesticides, as a solvent for the 
extraction of pharmaceuticals and as a precursor in the production of Freons. CT had a 
long history of use in industry before it was banned in 1970 in consumer products in the 
United States, followed by a complete ban in 1996 according to the Montreal protocol. 
CFC-11 was widely used as a refrigerant, foam-blowing agent, aerosol propellant and 
degreasing agent until 1996 when it was banned by the Montreal Protocol due to its 
contribution to stratospheric ozone depletion (1). Widespread use of these compounds 
combined with historically poor disposal practices, spills and leaks from underground 
storage tanks and recalcitrance to biodegradation has led to substantial soil and 
groundwater contamination. These compounds pose significant health and environmental 
concerns, especially at hazardous waste sites.   
 Among the many options for remediating contaminated groundwater, 
bioremediation offers numerous potential advantages, including sustainable, effective and 
economic removal. However, applying bioremediation to halogenated methanes requires 
developments in the technology, especially when the concentrations present are in the 
tens or hundreds of milligrams per liter. Although halogenated methanes receive less 
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attention than chlorinated ethenes, they are among the most significant groundwater 
contaminants.  The focus of this thesis is on developing improved methods to 
bioremediate high concentrations of CFC-11, CF, and DCM. 
1.1 CF and CFC-11 biodegradation 
 The well-established toxicity and frequency of occurrence of CF in groundwater 
poses significant challenges to its removal from the environment. As a consequence of 
the above factors, the Agency for Toxic Substances and Disease Registry (ATSDR) 2011 
Substance Priority List ranks CF eleventh overall, the third highest among chlorinated 
organic compounds, after vinyl chloride and polychlorinated biphenyls. Although not 
ranked as high as CF and CT on the ATSDR list of hazardous substances, CFC-11 is 
often found as a co-contaminant with CF and CT in groundwater (2). Among these three 
compounds, CF is considered the benchmark for evaluating the feasibility of 
bioremediation, due to its typically high level of toxicity towards most anaerobic 
prokaryotes (3). Inhibitory effects of low concentrations of CFC-11 on anaerobes have 
been reported as well (4).  At low concentrations of CFC-11 and in the absence of 
vitamin B12, the predominant end-product of CFC-11 degradation by Methanosarcina 
barkeri and sulfate-reducing microorganisms was dichlorofluoromethane, commonly 
known as HCFC-21 (4-5). However, halogenated methanes are not an acceptable end-
point for successful bioremediation. HCFC-21 is toxic, with an inhalation exposure limit 
(European MAK value) of 10 mg/m
3 
(6). Reductive dechlorination of HCFC-21 to 
chlorofluoromethane (commonly known as HCFC-31) has been reported under 
3 
methanogenic conditions (7). HCFC-31 is listed as a Group 3 carcinogen (8). In situ 
bioremediation of CFC-11 requires complete conversion into non-toxic products.  
 The fermentative enrichment culture DHM-1 was developed by Shan et al. (9) 
using soil and groundwater samples from a California industrial site.  DHM-1 is the first 
culture proven to cometabolically degrade high concentrations of CF, CT and CFC-11 
(500 mg/L, 10 mg/L and 26 mg/L, respectively) in the presence of catalytic amounts of 
B12 (i.e., 0.03 mol of B12 per mol of CT or CF). 
14
C analyses revealed that the dominant 
end products of CF and CT transformation in the presence of DHM-1, corn syrup, and 
B12 were CO, CO2 and organic acids (10); the presence of B12 shifts the pathway from 
reductive dehalogenation to hydrolytic and substitutive pathways (11-12).  Krone et al. 
(11) demonstrated the abiotic reduction of CFC-11 when titanium(III) citrate served as 
the electron donor and aquocobalamin as the catalyst, with CO representing 67% of the 
products and a corresponding amount of fluoride release. HCFC-21, HCFC-31, 
fluoromethane, and dichlorodifluroethane also accumulated; CO and fluoride are 
acceptable end-points. Egli et al. (13) have noted that anaerobic dechlorination of 
chlorinated methanes is often associated with microbes that possess the acetyl-CoA 
pathway.  The CO dehydrogenase in this pathway oxidizes CO to CO2.  The formation of 
dihalocarbenes (difluorocarbene in the case of CFC-11) during dehalogenation and 
hydrolysis reactions for halomethanes are toxic to anaerobes. The addition of exogenous 
B12 mitigates the toxic effects of these intermediate compounds on native coenzyme B12 
and CO dehydrogenase (14).  
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 Although the high unit cost of B12 is a concern, Wang (15) showed that doses 
lower than 3 mole percent are still effective for CF biodegradation by DHM-1.  The 
effect of B12 on the rate of CF biodegradation follows a Michaelis-Menton kinetic model, 
with a half saturation coefficient of 0.005 mol B12 per mol CF.  This information can help 
in the selection of a cost-effective dose of B12 to facilitate the bioremediation of CF and 
other halogenated methanes.  
 As with CT, reductive hydrolysis of CFC-11 to CO is well documented, as shown 
in Figure 1.1. In a previous study with the DHM-1 enrichment culture, 
14
C-labeled parent 
compounds were used to facilitate a complete mass balance of the daughter products of 
CT and CF biodegradation (10). However, the prohibitive cost of 
14
C-labeled CFC-11 
precluded its use for the evaluation of daughter products formed.  An alternative 
approach is to monitor release of fluoride, to determine if the non-volatile degradation 
products have been defluorinated.  One of the objectives of this thesis was to determine 
the percentage of fluoride recovery following complete degradation of CFC-11, in the 
presence of DHM-1, corn syrup, and B12.  
 The intended use for DHM-1 is bioaugmentation of source areas that contain CT, 
CF and/or CFC-11.  Source areas often contain dense, non-aqueous phase liquids 
(DNAPLs) that serve as a long-term source of groundwater contamination, with 
concentrations of halogenated methanes in the tens or hundreds of milligrams per liter.  
For bioaugmentation to be successful, it is necessary for the culture to grow under in situ 
conditions.  This translates to use of relatively low volumetric doses, e.g., less than 1%.  
The previous work by Shan et al. (10) was based on 5% transfers of DHM-1.  Although 
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effective, this dose was too high to be of practical value.  One of the objectives of this 
thesis was to evaluate the effect of the DHM-1 inoculum dose on the culture’s ability to 
biodegrade CF at 500 mg/L. 
1.2 DCM biodegradation 
 DCM (also commonly known as methylene chloride) was predominantly used as 
a paint and varnish stripper post World War II, with increased production over the years. 
It was also used as an aerosol propellant and a degreasing agent, and in the production of 
pharmaceuticals, adhesives and ink. However, post 1980, the production and demand for 
DCM began to drop dramatically. This has been attributed to increased regulation and 
concern over its carcinogenicity. The ATSDR 2011 Substance Priority List ranks DCM at 
86 (2). The national primary drinking water regulations have set the maximum 
contaminant level goal  and maximum contaminant level (MCL) for DCM at zero and 
0.005 mg/L, respectively.  As of January 2000, the Environmental Protection Agency 
(EPA) classified DCM as likely to be a human carcinogen by all routes of exposure. 
Long-term exposure to DCM above the MCL reportedly causes liver problems and 
increased risk to cancer (16).  
 In spite of its toxicity, the environmental fate of DCM is usually very favorable in 
comparison to other halogenated compounds. DCM is used as the sole carbon and energy 
source by several microorganisms under a variety of anaerobic conditions to produce 
non-toxic products (including CO2, Cl
-
 and organic acids). Under oxic conditions, DCM 
is readily degraded by methylotrophic bacteria harboring glutathione-dependent 
dehalogenases (17). A few studies have demonstrated DCM degradation under 
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denitrifying (17), acetogenic (13, 18) and methanogenic conditions (19). Mägli et al. (20) 
subsequently isolated a novel anaerobic bacterium, Dehalobacterium formicoaceticum 
strain DMC, that uses DCM as its sole source of organic carbon and energy, forming 
acetate and formate as products. They also proposed a pathway for DCM degradation by 
strain DMC, as shown in Figure 1.2. 
 The DCM enrichment culture used in this research was developed by Wang (15), 
using inoculum from a microcosm study conducted at Clemson University. It was 
gradually acclimated to consume up to 500 mg/L of DCM, which inhibited 
methanogenesis (21-22). Kanitkar (23) demonstrated that DCM can serve as the sole 
electron donor for reductive dechlorination of tetrachloroethene to ethene.  This is of 
particular relevance for sites in which chlorinated ethenes and DCM are comingled.  
Since reductive dechlorination of chlorinated ethenes to ethene requires the participation 
of Dehalococcoides (at a minimum, for reduction of cis-dichloroethene to vinyl chloride 
and ethene), and hydrogen is the only electron donor known for Dehalococcoides, use of 
DCM as the only electron donor implies that hydrogen was one of the fermentation 
products.  Presumably this occurred via disproportionation of formate to hydrogen and 
carbon dioxide.  Kanitkar (23) measured hydrogen at the end of his experiments and it 
was below detection.  He mentioned that higher levels were detected in other studies with 
the DCM enrichment culture, but no data were presented.  One of the objectives of this 
thesis was to provide evidence of hydrogen formation during fermentation of DCM by 
the enrichment culture.    
7 
 The DCM fermentation pathway proposed by Mägli et al. (20) (Figure 1.2) is 
summed up by the following equations: 













  → CO2 + H2  (1.2)  
Lee et al. (24) propose that DCM fermentation may yield hydrogen rather than formate: 
 3CH2Cl2 + 4H2O →CH3COO
−





Each of these reactions is thermodynamically favorable under standard conditions, with 
Gibbs free energies of -674, -43.4, and -681 kJ/mole of rxn, respectively (the free 
energies of formation used to calculate these values are shown in Appendix A). However, 
it is unknown if one of the intermediate steps may be inhibited by accumulation of H2.  
Lee et al. (24) observed inhibition of DCM fermentation when 20% hydrogen was 
present in the headspace of their enrichment culture.  One of the objectives of this thesis 
was to determine if accumulated hydrogen inhibits DCM fermentation by Clemson’s 
DCM enrichment culture.   
 DCM is one of the most soluble of the halogenated organic solvents, reaching 
approximately 20,000 mg/L at saturation at 20°C (25). Consequently, at hazardous waste 
sites that have DNAPL pools of DCM, the aqueous phase concentration will likely be 
above 1,000 mg/L.  One of the objectives of this thesis was to evaluate the ability of 
Clemson’s DCM enrichment culture to grow at DCM concentrations above 500 mg/L, 
the highest level previously evaluated.   
 Grostern et al. (26) recently demonstrated that a Dehalobacter sp. reductively 
dechlorinates CF to DCM via organohalide respiration.  Interestingly, Justicia-Leon et al. 
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(27) reported that a DCM-degrading culture also consisting of a Dehalobacter sp. 
obtained from pristine river sediment, did not reductively dechlorinate CF to DCM; 
instead, their enrichment fermented DCM to acetate. This suggests that distinct 
Dehalobacter populations are responsible for CF reductive dechlorination and DCM 
fermentation. This observation was verified in the report by Lee et al. (24) where an 
enrichment culture from a subsurface aquifer in Sydney, Australia was found to 
completely dechlorinate up to 40 mg/L of CF. First, CF was respired to DCM, followed 
by fermentation of DCM to acetate, H2 and CO2. Dehalobacter lineages were found to be 
responsible for both dehalorespiration and fermentation. This contrasts to the earlier view 
that Dehalobacter spp. are strictly characterized as organo-halide respiring organisms and 
could not use other substrates for growth (26, 28). However, the CF-degrading culture 
studied by Lee et al. (24) was inhibited by high partial pressures of H2. Results from this 
thesis will elucidate if accumulation of H2 by DCM fermentation inhibits the Clemson 
DCM enrichment culture in a similar manner.  The DCM-degrading culture developed by 
Justicia-Leon et al. (27) was completely inhibited in the presence of 5 mg/L CF. For sites 
co-contaminated with CF and DCM, bioaugmentation with a microbial consortium 
consisting of both CF-to-DCM respiring Dehalobacter sp. and a DCM-fermenting culture 
will hold significant promise in the complete detoxification of CF.  The prospect exists 
that fermentation of DCM can provide the electron donor needed for reduction of CF to 
DCM, resulting in a mixed culture that requires no external inputs yet results in 
degradation of CF to nonhazardous products. This would require acclimating a DCM-
fermenting culture to increasing concentrations of CF, as that seen in heavily 
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contaminated sites.  One of the objectives of this thesis was to evaluate the sensitivity of 
the Clemson DCM enrichment culture to CF.   
 In addition to the Dehalobacter sp. reported by Justicia-Leon et al. (27) 
Dehalobacterium, a member of the Firmicute phylum, also grows anaerobically on DCM 
as a sole carbon and energy source.  Microscopic evaluation of Clemson’s DCM-
fermenting culture by Kanitkar (23) indicated the prevalence of gram positive short rods, 
characteristic of Dehalobacterium formicoaceticum strain DMC.  PCR amplification with 
Firmicute specific primers and clone library construction with DNA from the DCM 
enrichment culture revealed the presence of Firmicutes. One of the objectives of this 
thesis was to further characterize the identity of the microbe responsible for fermentation 
of DCM in Clemson’s enrichment culture. 
 Thus, the overall objective of this thesis was to evaluate strategies to remediate 
high concentrations of CFC-11, CF and DCM in contaminated groundwater, focused 
mainly on further characterizing the DHM-1 enrichment culture developed by Shan et al. 
(9), and the DCM enrichment culture developed by Wang (15). 
The specific objectives were: 
1) To determine a mass balance for fluoride release during biodegradation of 
CFC-11 by DHM-1, in the presence of corn syrup and B12; 
2) To evaluate the effect of the inoculum dose of DHM-1 on the 
biodegradation rate of 500 mg/L of CF;  
3) To evaluate the tolerance of the Clemson DCM enrichment culture to 
DCM concentrations greater than 500 mg/L;  
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4) To determine the effect of CF on DCM biodegradation by Clemson’s 
DCM enrichment culture, including the potential for acclimation to 
increasing concentrations of CF;  
5) To confirm the accumulation of hydrogen during DCM biodegradation by 
Clemson’s DCM enrichment culture; 
6) To evaluate the effect of hydrogen concentration on DCM biodegradation 
by Clemson’s DCM enrichment culture; and  
7) To further characterize the identity of the microbe responsible for DCM 















CHAPTER TWO: MATERIALS AND METHODS 
2.1 Chemicals and media 
 The purity and sources of chemicals used for this research were as follows. CF 
(99.7%, Shelton Scientific), DCM (99.9%, Allied Signal) and CS2 (100%, J.T. Baker) 
were obtained as neat liquids. Chloromethane (methyl chloride, 99%, Praxair) and 
methane (99.99%, Matheson) were obtained as neat gases. A gas mixture of 30% 
CO2/70% N2 was obtained from Airgas. High purity hydrogen gas (99.99%) was obtained 
from National. Regular type corn syrup was obtained from Sweetener Products 
Company. A stock solution of corn syrup was prepared (5 mM), with a chemical oxygen 
demand (COD) of 360 mg/mL based on its presumed composition of glucose (C6H12O6). 
USP grade Vitamin B12 (cyanocobalamin) was obtained from Research Organics Inc. All 
other reagents were ACS reagent grade or higher.  
 The two enrichment cultures used in this research were grown in different types 
of medium.  The DHM-1 culture was grown in a previously described (29) mineral salts 
medium (MSM-1), with the following modifications: NaCl and KH2PO4 were not added; 
the concentrations of K2HPO4 and NaHCO3 were 0.41 g/L and 4.0 g/L, respectively; and 
the headspace consisted of 30% CO2/70% N2. Sodium sulfide (0.5 mM) was added to 
MSM-1 in an anaerobic chamber.  A protocol for preparing MSM-1 is provided in 
Appendix B.1. The DCM enrichment culture was maintained in a modified bicarbonate 
and phosphate buffered medium, hereafter referred to as MSM-2.  A protocol for 
preparing MSM-2 is provided in Appendix B.2. For the isolation of the microbe involved 
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in DCM degradation, a formulation was adapted from Mägli et al. (18) to prepare both 
liquid medium (hereafter referred to as MSM-3) and semi-solid agar medium. A protocol 
for preparing the both is provided in Appendix B.3. 
2.2 Experimental design 
 This section is organized according to the objectives, with objectives #1 and #2 
covering the DHM-1 enrichment culture and objectives #3 through #7 covering the DCM 
enrichment culture.     
2.2.1 Fluoride mass balance during CFC-11 degradation by DHM-1 
 Three sets of experiments were conducted to measure the percentage of fluoride 
recovery during biodegradation of CFC-11 by the DHM-1 enrichment culture.  CFC-11 
was added to all but one treatment, to provide an initial aqueous phase concentration of 
26 mg/L.  The first experiment (Set I) consisted of three treatments (Table 2.1). All 
received MSM-1, a 5% dose of the DHM-1 enrichment culture (v/v), 13.5 µM CS, and 
136 µM B12 (approximately 22% of the total CFC-11 on a molar basis).  Treatment A 
received only CFC-11; B was used to determine the impact of CF on biodegradation of 
CFC-11; and C served as a control for the DHM-1 culture, so only CF was added.  
Fluoride concentrations were measured at the start and end of the incubation period 
(based on complete removal of the CFC-11 and CF).    
 The treatments used for the Set II experiment are outlined in Table 2.2.  
Treatment A received DHM-1, CS, and B12, while B12 was not added to treatment B (with 
the expectation that this would slow the rate of CFC-11 degradation and alter the 
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products formed).  Treatments C and D served as abiotic controls, with and without B12 
added, respectively.  With Set II, fluoride concentration was monitored multiple times 
throughout the incubation period, to examine if accumulation of fluoride coincided with 
CFC-11 degradation.   
 The treatments for Set III were identical to Set II (Table 2.2).  However, there 
were several key difference between these sets:   1) For Set II, CFC-11 was added as a 
neat liquid.  Due to some concerns about the accuracy of this method, and its impact on 
the outcome of the fluoride mass balance, CFC-11 was added to Set III as a methanol 
stock solution.  Introducing CFC-11 in methanol afforded better control over the amount 
added; the presence of methanol did not affect CFC-11 degradation by the DHM-1 
enrichment culture.; 2) For Set III, fluoride was measured only at the start and end of the 
incubation period; and 3) For Set III, the DHM-1 culture was washed before adding it to 
treatments A and B.  The intent of washing was to remove the residual level of B12 and 
soluble organics. Washing consisted of centrifuging 40 mL of the DHM-1 culture using a 
SORVALL® Evolution™ RC superspeed centrifuge. The supernatant was decanted and 
the concentrate was resuspended in 40 mL of freshly prepared MSM-1. This suspension 
was centrifuged once more, the supernatant decanted, and the concentrate was again 
resuspended in 40 mL of fresh MSM-1.  
 The experiments were performed in autoclaved 160 mL serum bottles, which 
were prepared in an anaerobic chamber (Coy Laboratories) containing an atmosphere of 
approximately 95% N2 and 5% H2. Resazurin (1 mg/L) was added to the MSM-1 to serve 
as a redox indicator.  Addition of Na2S·9H2O (120 mg/L) resulted in the medium turning 
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clear, an indication that the Eh had dropped to below -110 mV. DHM-1 was then added to 
the appropriate treatments (Tables 2.1 and 2.2).  The bottles were then stoppered with 
grey butyl septa and taken out of the anaerobic chamber.  The headspace of the bottles 
was sparged for 1 min with 30% CO2/70% N2 to remove the hydrogen and adjust the pH 
to circumneutral. They were then sealed with Teflon-faced red rubber septa and 
aluminum crimp caps. Lastly, CFC-11, CF, CS and B12 were added to the respective 
treatments (Tables 2.1 and 2.2).   The bottles were incubated (liquid in contact with the 
septum) for at least 1 h on a shaker table and then headspace samples were analyzed to 
determine the initial concentrations of the volatile compounds.   
 The pH of bottles was checked periodically and adjusted to 6.8 and 7.4 by the 
addition of 8 M NaOH.  Decreases in pH were most pronounced in bottles containing the 
DHM-1 culture, CS and B12. This was indicative of the accumulation of organic acids, as 
well as release of HCl and HF due to dehalogenation. 
2.2.2 Effect of the DHM-1 inoculum dose on the rate of CF biodegradation 
 The experimental design for evaluating the effect of DHM-1 dose on CF 
biodegradation employed 10 treatments (Table 2.3).  One half of the treatments were 
“live,” i.e., they received doses of DHM-1 ranging from 10
-8
 to 5.0% (v/v).  Serial 
dilutions of the DHM-1 culture were used to achieve varying initial doses.  The other five 
treatments consisted of various types of abiotic controls, according to whether or not CS 
or B12 was added.     
 Treatments A through I were prepared in the same manner as described in the 
previous section, starting with addition of MSM-1 to the 160 mL serum bottles in an 
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anaerobic chamber.  Aseptic technique was used to ensure the proper doses of DHM-1 
were added and that no microbes were added to the controls.  The water controls (WC) 
were prepared on the bench top and received 100 mL of distilled deionized (DDI) water 
plus 36 µL of neat CF. 
2.2.3 Tolerance of the DCM enrichment culture to high DCM concentrations 
 Acclimation to increasing concentrations of DCM was gradually achieved in 160 
mL serum bottles containing 100 mL of the DCM enrichment culture growing in MSM-2 
(Appendix B.2). These bottles (labeled 5-1T, 5-2T and 5-3T) were inherited from 
Kanitkar (23) and were maintained for this research.  pH was monitored periodically; the 
culture was observed to be sensitive to pH levels below ~6.5. To maintain the pH 
between 6.8 and 7.4, 8 M NaOH was periodically added.  To prevent an inhibitory 
accumulation of salts (from NaOH neutralization of HCl), aliquots of culture were 
periodically removed and replaced with fresh MSM-2. 
2.2.4 Effect of CF and H2 on DCM biodegradation 
 In order to evaluate the effect of CF (1 mg/L) and increased partial pressures of 
H2 on DCM biodegradation, experiments were set up in 70 mL serum bottles; treatments 
are outlined in Table 2.4. The DCM enrichment culture (growing in a 2350 mL bottle) 
was added (44 mL) to each of the bottles in an anaerobic chamber. The bottles were 
immediately stoppered with grey butyl septa and removed from the glove box. The 
headspace was sparged with 30% CO2/70% N2 and the bottles were sealed with 
aluminum crimp caps. The pH was further adjusted between 6.8-7.4 by the addition of 8 
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M NaOH.  Treatment A received DCM and CF, while treatment B received DCM and H2.  
Treatment C served as a control for DCM consumption (no CF or H2 added) and D as a 
control for H2 consumption (no DCM added).  When H2 was consumed, increasing 
amounts were added, up to 60 µmol/bottle.  pH was maintained between 6.8 and 7.4.  
 Preliminary results from this experiment indicated 1 mg/L of CF was inhibitory to 
DCM biodegradation.  Consequently, a second experiment was prepared at a series of 
lower CF concentrations, ranging from 0.1 to 0.8 mg/L (Table 2.5). The bottles were 
prepared in the same manner as described above. 
2.3 Enrichment cultures 
 The DHM-1 culture developed by Shan et al. (9) was maintained in 160 mL 
serum bottles by sequential transfers in MSM-1.  Transfers were initiated by adding 5% 
of the culture (v/v) along with MSM-1, CS, B12 and 500 mg/L CF, totaling 100 mL of 
liquid.  Once CF in the bottle was completely consumed (approximately 30 days), the 
transfer process was repeated.  At the time of each transfer, the excess culture was 
available for use in experiments.   
 The DCM culture developed by Wang (15) was initially maintained in 160 mL 
serum bottles containing MSM-2.  Repeated additions of DCM were consumed; the pH 
was maintained in the range of 6.8 and 7.4.  As needed, samples were removed to initiate 
experiments and the volume was replaced with MSM-2.  For experiments that evaluated 
inhibition by CF and H2, a larger supply of culture was needed.  This was created by 
transferring one of the serum bottles to a 2.35 L glass bottle, prepared with the same 
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liquid to headspace ratio as in the serum bottles.  When samples of the culture were 
removed, an equivalent volume of MSM-2 was added. 
2.4 Analysis of volatile organic compounds 
 A Hewlett Packard 5890 Series II gas chromatograph (GC) equipped with a flame 
ionization detector (FID) and a 2.44 m  3.175 mm column packed with 1% SP-1000 on 
60/80 Carbopack B (Supelco) was used for the analysis of volatile organic compounds. 
Halogenated (CF, DCM, CM, CFC-11, HCFC-21, HCFC-31) and nonhalogenated 
volatile compounds (methane, methanol, CS2) were monitored by analysis of 0.5 mL 
headspace samples using a Pressure-Lok analytical syringe (1.0 mL). Standard curves of 
each of the above compounds provided a response factor which was used to quantify the 
mass of the compound in the bottle. Results were reported in terms of micromoles per 
bottle, in order to easily reveal the stoichiometry of the transformations. Representative 
response curves are shown in Appendix A.  Assuming that equilibrium is established 
after the compound partitions between the gas phase and the aqueous phase, the aqueous 
phase concentration is determined from the total mass of the compound present by the 
following equation:  
 
   
 
       
   
(2.1) 
where Cl is the concentration in the aqueous phase (µM); M is the total mass present 
(µmol/bottle); Vl is the volume of liquid in the bottle (L); Vg is the volume of headspace 
(L); Hc is the dimensionless Henry’s constant at 23°C (30-31). The detection limit of this 
method is lower than the MCL for each of the chlorinated compounds. 
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2.5 Analysis of fluoride 
 Fluoride concentrations were quantified using a Dionex 2100 Ion Chromatograph 
(IC). A mobile phase of degassed sodium carbonate/bicarbonate eluent (4.5 mM and 0.8 
mM, respectively) was pumped (1.0 mL/min) through an IonPac® AG9-HC guard 
column (4 mm x 50 mm), followed by an IonPac® AS9-HC anion-exchange column (4 
mm x 250 mm. Samples (0.2 mL) from the serum bottles were prepared by a 1:50 
dilution in DDI water, followed by filtration (0.2 µm PTFE) into 5 mL IC vials.  Sample 
dilution was essential to reduce interference from other anions in the MSM-1, especially 
chloride.  Samples were injected onto the column using a 250 µL injection loop.  Fluoride 
calibration standards were prepared according to EPA method 9214. A series of 1:50 
dilutions of a stock solution (1,000 mg/L) was made in MSM-1; these were further 
diluted 1:10 in DDI water (the same as the samples), yielding IC calibration standards of 
2000, 1400, 1000, 500 and 100 µg/L. Standards were also filtered. A representative 
calibration curve is shown in Appendix C.  
 The percent recovery of fluoride (RF) was calculated as follows: 
 
   
          
                               
       
(2.3) 
where Ff  and Fi = the final and initial fluoride concentrations (µM), respectively; Vl = 
volume of liquid (0.10 L/bottle); CFC11i and CFC11f =  the initial and final amounts of 
CFC-11 (µmol/bottle), HCFC21f = final amount of dichlorofluoromethane (µmol/bottle); 
HCFC31f = final amount of chlorofluoromethane (µmol/bottle).  The initial amounts of 
dichlorofluoromethane and chlorofluoromethane were zero.   
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 To assess the impact of quantifying fluoride in a complex matrix (i.e., MSM-1 
and soluble biodegradation products), fluoride recovery was measured by standard 
addition.   After dilution (1:50) and filtration of samples from bottles with DHM-1, CS, 
B12 and CFC-11, 5 mL was added to an IC vial. An aliquot (2.5 mL) of this solution was 
mixed with 2.5 mL of the 1000 µg/L filtered IC standard in another vial. In a third vial, 
2.5 mL of the 1000 µg/L standard was mixed with 2.5 mL of filtered DDI water. The 
percentage recovery from this standard addition (RSF) was calculated by the following 
equation: 
 
    
      
 
       
(2.3) 
where A is the fluoride concentration in the sample + standard (50:50 mixture by volume; 
µg/L), B = fluoride concentration in the sample (µg/L), and C = concentration of the 
fluoride standard after mixing 50:50 (v/v) with DDI water. 
2.6 Agar dilution series and transfers 
 Isolation of the microbe in the DCM enrichment culture responsible for DCM 
biodegradation involved induction of colony growth in Balch tubes by agar shake dilution 
series, followed by transfer of individual colonies to liquid medium in Balch tubes, as 
previously described (18). Two batches of agar shake tubes were prepared; one 
containing DCM culture filtrate and the other without. All of the test tubes were serially 
diluted.  
 For the batch of test tubes without culture filtrate, MSM-3 was prepared 
according to Mägli et al. (18) (Appendix B.3).  MSM-3 was made semi-solid by the 
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addition of 0.3% agar (w/v), and 10 mL of it was transferred to six Balch tubes in an 
anaerobic chamber. The tubes were immediately stoppered with grey butyl septa, 
crimped and removed from the chamber. The headspace was sparged with filter sterilized 
30% CO2/70% N2.  The tubes were placed in a water bath on the bench top to melt the 
agar. A thermometer placed in the water bath ensured that the temperature was between 
45°C and 50°C. An aliquot (1 mL) of the enrichment culture was transferred to the first 
Balch tube. The tube was gently swirled to mix the semi-solid medium and culture, and 
to prevent the formation of gas bubbles. After mixing, 1 mL from the first tube was 













. Filter-sterilized DCM-saturated water (0.23 mL) was 
added to each of the test tubes and gently swirled to mix. The tubes were removed from 
the water bath and placed in the upright position in the dark.  The tubes were checked 
periodically for development of colonies.  
 The batch containing culture filtrate was prepared following the same 
methodology as described above, except for the addition of filtrate from the DCM 
enrichment culture, in a 50:50 combination with sterile MSM-3. The culture filtrate was 
prepared by dispensing 55 mL of the enrichment culture to a centrifuge tube inside the 
anaerobic chamber, removing the tube from the chamber, and centrifuging it (10,000 
rpm, 20 min, SORVALL® Evolution™ RC superspeed centrifuge). The tube was 
returned to the anaerobic chamber and the supernatant passed through a sterile 0.2 µm 
syringe filter. Sterile culture filtrate and MSM-3 were mixed and the product was made 
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semi-solid by the addition of 0.3% agar (w/v). Serially diluted tubes were prepared and 
incubated in the same manner described above.  
 Whitish colonies were observed in the both batches of test tubes within 4-5 weeks 
of incubation. Several colonies from the tubes were used to inoculate 10 mL of sterile 
MSM-3 in Balch tubes. Individual colonies were transferred using a sterile Pasteur 
pipette, sterile rubber tube and a 5 mL syringe to provide suction. Care was taken to 
ensure that only a single colony was picked . More than 20 such colonies were transferred 
to different test tubes. The tubes were sealed and taken out of the anaerobic chamber; the 
head space was sparged with the filter sterilized CO2 +N2 gas mix; filter sterilized DCM 
saturated water  (0.23 mL) was added to each tube and incubated in an inverted position. 












CHAPTER THREE: RESULTS 
3.1 Characterization of DHM-1 enrichment culture 
3.1.1 Fluoride mass balance during CFC-11 degradation 
 A mass balance for fluoride release during biodegradation of CFC-11 by the 
DHM-1 enrichment culture in the presence of CS and B12 resulted in recoveries of 92-
102% (Table 3.1).  These recoveries take into account the minor amount of fluoride that 
resided in the CFC-11 dehalogenation daughter products, HCFC-21 and HCFC-31 
(Figures 3.1-3.3).  Thus, nearly all of the CFC-11 consumed by DHM-1 in the presence 
of CS and B12 resulted in a stoichiometric increase in fluoride.  Standard recoveries for 
fluoride were approximately 100% (Appendix D), indicating the sample matrix imparted 
no bias in determining fluoride concentrations.     
 Headspace monitoring results for the Set I treatment with DHM-1, CS and B12 
(identified as I-A in Table 3.1) are shown in Figure 3.1.  Results for the same treatment 
but with 500 mg/L of CF also added (identified as I-B) are shown in Figure 3.2.  The 
initial increase in CFC-11 in comparison to the time zero value appears to be a 
consequence of a disequilibrium between the headspace and aqueous phases.  The 
presence of CF did not slow the rate of CFC-11 biodegradation, while the rate of CF 
biodegradation was slowed by the presence of CFC-11.  The presence of CF had no 
impact on the fluoride mass balance for CFC-11 (Table 3.1).  Methane did not 
accumulate throughout the incubation period and carbon disulfide, a potential hydrolytic 
product from CFC-11 (Figure 1.1), was not detected.   
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 Figure 3.3 shows the results for CFC-11 and other volatiles in the Set II treatment 
with DHM-1, CS and B12 (identified as II-A in Table 3.1), and for the treatment with only 
MSM-1 (II-D).  During this experiment, it is apparent that fluoride release coincided with 
biodegradation of CFC-11.  Over the same incubation period, the net decrease in CFC-11 
(initial versus final value) was 6% in the treatment with only MSM-1 present.  Headspace 
monitoring results for treatments B and C are shown in Appendix E.2; biodegradation of 
CFC-11 was incomplete in these bottles and yielded a lower mass balance for fluoride 
compared to the treatment with CS and B12 added.   
 Results for CFC-11 in the Set III treatments are shown in Figure 3.4a.  Complete 
consumption of CFC-11 occurred only in treatment A (DHM-1, CS and B12 added).  As 
indicated in section 2.2.1, CFC-11 was provided dissolved in methanol to improve the 
accuracy of addition (in comparison to adding a smaller volume of neat compound, as 
was done in Sets I and II).  The presence of methanol had no apparent impact on the rate 
of CFC-11 biodegradation (comparing Figures 3.1-3.3 to 3.4).  Methanol was not 
quantified but the peak area indicates it persisted while CFC-11 was present and then 
decreased rapidly after CFC-11 was consumed.  There was no net consumption of CFC-
11 in the treatments without B12 added (B and D), in comparison to partial degradation of 
CFC-11 in the abiotic treatment with only B12 added (C).  The fluoride balance was also 
incomplete for this treatment, similar to what occurred with the same treatment for Set II 
(Table 3.1). Headspace monitoring results for the individual treatments are shown in 
Appendix E.3. 
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3.1.2 Effect of DHM-1 inoculum dose on the rate of CF biodegradation 
 As indicated in Figure 3.5, biodegradation of 450-500 mg/L of CF proceeded at a 
high rate even at an inoculum dose as low as 10
-8 
percent.  Headspace monitoring 
continued until CF fell below the MCL for trihalomethanes (80 µg/L).  At a 5% inoculum 
dose, 23 days of incubation was required. Previous subcultures of 5% inoculum also 
degraded 500 mg/L CF in approximately 20 days (9), which provides evidence that the 
CF biodegradation ability of the culture did not change significantly with time. The 10
-8
% 
dose took 39 days to completely biodegrade CF.  Accumulation of DCM and CM 
amounted to less than 0.6% of the CF consumed, which is consistent with results reported 
by Shan et al. (9) for a 5% inoculum dose.  Losses from uninoculated controls were 
comparatively minor over the 39 days of incubation.  These results demonstrate the 
potential for DHM-1 to biodegrade 500 mg/L CF even at a low initial cell density, which 
is an essential characteristic for use in bioaugmentation.   
 Maximum initial rates of CF biodegradation are summarized in Table 3.2, 




.  The rates were determined by fitting a trend line to at least 
the first three data points; other time points were included as long as the slope remained 
statistically significant (p<0.025); an example is shown in Appendix E.4.  Three of the 
five uninoculated controls had statistically significant rates of decrease in CF, although 
the rates were one to two orders of magnitude lower than that of the live treatments. 
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3.2 Characterization of a DCM degrading anaerobic enrichment culture 
3.2.1 Effect of DCM dose and hydrogen accumulation 
 The DCM enrichment culture was able to degrade successively higher doses of 
DCM, as shown in Figure 3.6. Treatment 5-1T tolerated and degraded 914 µmol/bottle, 
which is equivalent to 740 mg/L, the highest level tested. It is not yet known if the culture 
will tolerate even higher concentrations.  Maintenance of the pH became especially 
demanding as the concentration was increased, due to the higher rate of release of HCl.  
The effect of pH on the activity of the culture was not explicitly evaluated.  However, on 
occasions when the pH dropped below 6.4, the rate of DCM biodegradation slowed 
significantly and recovery after raising the pH to circumneutral often took several weeks.  
Accumulation of salts from acid neutralization also required that portions of the medium 
be removed periodically and replaced with fresh MSM-2.  Further work is needed to 
define the effect of salt concentration on DCM biodegradation in the Clemson DCM 
enrichment culture.    
 Increases in hydrogen were most pronounced shortly after adding DCM.  
Hydrogen reached a maximum of approximately 27 µmol/bottle (Figure 3.6) and 
typically decreased as the DCM was biodegraded. This observation confirmed the 
availability of hydrogen from DCM to serve as an electron donor for reductive 
dechlorination of PCE to ethene, as demonstrated by Kanitkar (23).  It also formed the 
basis for the experiment described below to determine if increased hydrogen 
concentrations would cause a thermodynamic barrier to DCM degradation. 
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3.2.2 Effect of H2 and CF on DCM degradation 
 The effect of hydrogen on DCM biodegradation was evaluated to determine if 
high partial pressures of hydrogen inhibited DCM degradation. Thermodynamic 
calculations for equations 1.1 to 1.3 predict the reactions will be favorable under standard 
conditions (ΔG°’ < 0). Hence, hydrogen levels at least as high as 1 atm should not inhibit 
these reactions.  Experiments were performed in 70 mL serum bottles containing 44 mL 
of the DCM enrichment culture.  One set of triplicate bottles received DCM (173 mg/L 
DCM) and increasing additions of hydrogen (from 4 to 60 µmol/bottle, or 0.4 to 6% of 
the headspace volume); one set of controls received only DCM and another only 
hydrogen.  Whenever DCM or hydrogen was consumed, more was added; rates of 
consumption increased over time (Appendix F).  As shown in Figure 3.7a, the presence 
of added hydrogen did not slow the cumulative rate of DCM biodegradation; likewise, 
the presence of DCM did not slow the rate of hydrogen consumption (Figure 3.7b).  In 
the controls with only hydrogen, approximately 60% of the electron donor (H2) was 
converted to methane; in the treatments with DCM added, 16-22% of the electron donor 
(DCM and H2) was recovered as methane.  This indicated that 173 mg/L of DCM was not 
completely inhibitory to methanogenesis, as it was when higher concentrations of DCM 
were added (Figure 3.6).  It is possible that some of the hydrogen was also converted to 
organic acids, as reported by Kanitkar (23); however, organic acids were not quantified in 
the research for this thesis.         
 The effect of CF on DCM biodegradation was also evaluated, since both 
compounds may be present simultaneously in anaerobic groundwater.  Experiments were 
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performed in 70 mL serum bottles containing 44 mL of the DCM enrichment culture.  
The first evaluation consisted of a treatment with DCM (173 mg/L) plus 1 mg/L of CF.  
As shown in Figure 3.7a, this level of CF completely inhibited DCM biodegradation, in 
comparison to the control that received DCM but no CF.   
 To determine the effect of lower CF doses, a second experiment was performed, 
using the same experimental system described above.  Increasing doses slowed the rate of 
DCM biodegradation, but did not prevent it (Figure 3.8a); CF levels stayed relatively 
constant throughout the incubation period, indicating that the DCM enrichment is unable 
to biodegrade CF.  All of the bottles subsequently received a second dose of DCM and an 
increased dose of CF, to determine if acclimation to CF is possible.  Although still in 
progress, results suggest that DCM biodegradation is continuing at CF levels above 1 
mg/L (Appendix G). 
3.2.3 Isolation and microscopic observation of DCM fermenters 
 The microbial community within the DCM enrichment culture was investigated 
using a light microscope. Phase contrast and gram staining techniques were applied using 
oil immersion and 1000X magnification. Photomicrographs showed a diversity of 
microbes in the enrichment culture, including gram positive rods and cocci, and gram 
negative rods and filaments, enmeshed in iron sulfide particles from the MSM-2.  
 Following 6 weeks of incubation in the agar tubes, distinct colonies developed.  A 
random selection of colonies was picked and transferred aseptically to Balch tubes 
containing MSM-3 and DCM saturated water.  The relative amount of DCM remaining 
was determined by headspace analysis.  As shown for representative tubes in Figure 3.9, 
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the DCM was consumed in approximately 44 days, in tubes inoculated with colonies 
from dilutions with and without enrichment culture filtrate (suggesting that the filtrate 
was not required).  A higher rate of DCM consumption ensued after respiking.  
Consumption of DCM was accompanied by an increase in turbidity, indicative of growth.  
Phase contrast and gram stain photomicrographs for samples taken from representative 
Balch tubes are shown in Figure 3.10. Microbes from both tubes were gram positive. The 
predominant morphology was thick single rods, which sometimes occurred in pairs. 
These rods had an average length of 3.0 µm. This was followed by thin rods that occurred 
as filaments or as single rods. These rods had an average length of 2.0 µm. These results 
indicate that some of the rods observed may be Dehalobacterium sp., which is known to 









CHAPTER FOUR: DISCUSSION 
 The results of this study provide information that will be helpful in applying 
bioremediation to high concentrations of CFC-11, CF, and DCM.  With respect to CFC-
11, the results demonstrated that the DHM-1 enrichment culture amended with CS and 
B12 completely biodegraded 26 mg/L, with stoichiometric release of fluoride. Fluoride 
recovery was close to 100% for all the bottles containing DHM-1, CS, and B12, with 
minimal accumulation of HCFC-21 and HCFC-31. This indicates that the DHM-1 culture 
has potential for application in the field to degrade high concentrations of CFC-11 (i.e., 
26 mg/L), with minimal formation of harmful intermediate fluorinated products. Hence, 
the potential exists for using this culture to biodegrade CF, CT and CFC-11 to non-toxic 
end products. Treatments that contained DHM-1 and CS, but no B12, showed negligible 
CFC-11 and fluoride release, similar to the treatments that contained no inoculum.  This 
demonstrates the crucial catalytic role played by B12 in biotransformation (32). However, 
sterile treatments in sulfide-reduced MSM-1 that contained B12 showed a significant level 
of CFC-11 consumption and fluoride release. This is attributed to abiotic degradation 
with the influence of the sulfide-reduced MSM-1 and B12 (33). 
 Results from the DHM-1 inoculum dose experiment established that levels below 
what was previously tested (i.e., 5% v/v) (9) are feasible for biodegrading CF 
concentrations of approximately 500 mg/L.  As shown in Figure 3.5 and Table 3.2, CF 
degradation rates with a 5% dose and a 10
-2
% dose were not significantly different. 






% also showed significant rates of CF 
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biodegradation. An inoculum dose of 5% would be impractical for field applications. 
Bioaugmentation field tests at Department of Defense facilities (34) have shown that a 
dose of 10
-3
% by volume was required to effectively remediate chlorinated-ethene 
contaminated sites by addition of an enrichment culture dominated by Dehalococcoides. 
For chlorinated ethenes, a commonly used target is 10
7
 cells/L of Dehalococcoides (34).  
Assuming a unit mass of 1.6x10
-14
 g/cell (35)  and one half of the cell mass is protein, 
this equates to a dose of  8x10
-5
 mg/L protein.  DHM-1 was able to biodegrade 500 mg/L 
of CF at a high rate with a volumetric dose as low as 10
-8
%; this equates to a 
concentration of 10
-8
 mg/L protein, several orders of magnitude lower than the target for 
Dehalococcoides.  This suggests that achieving an adequate dose in situ will not be 
problematic, thereby improving its potential for use in bioaugmentation. Among the 
sterile controls, those that contained B12 showed a slow decrease in CF levels, which can 
be attributed to abiotic degradation in the presence of B12. The sterile water treatment and 
controls without B12 did not show a decrease in CF.     
 Several characteristics of the DCM degrading culture revealed by this study lends 
itself to application of the culture at field sites where high concentrations of DCM are 
found. The biodegradative capability demonstrated by the DCM enrichment culture is 
amenable in locations where high concentrations of DCM are found. As shown in panel a 
of Figure 3.6, the enrichment culture has the ability to degrade at least 740 mg/L DCM; 
the highest concentration reported previously is 425 mg/L (36). Additional studies are 
needed to determine just how high a DCM concentration the Clemson enrichment culture 
can tolerate. However, since the culture is sensitive to decreases in pH below ~6.5, 
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buffering agents need to be added periodically, along with attention to avoiding an 
inhibitory accumulation of salts from neutralization (37).   
 CF has an inhibitory effect on DCM degrading microbes, as reported in previous 
studies (27). This was visible in the treatment containing 1 mg/L CF and 173 mg/L in this 
research (Figure 3.7a). However, treatments with CF levels below 1 mg/L did not show 
complete inhibition of DCM removal, albeit, the treatment with 0.8 mg/L CF showed 
slower DCM degradation than the treatment with  0.1 mg/L CF  (Figure 3.8).  The bottles 
that demonstrated DCM removal in the presence of CF were respiked with 173 mg/L of 
DCM and a CF concentration higher than the initial amount to deduce the tolerance as 
well as acclimate the culture to higher CF levels. A culture that tolerates sufficiently high 
concentrations of CF could be used as a bioaugmentation culture at CF contaminated 
sites.  A previous study showed that Dehalobacter spp. are responsible for the reductive 
dechlorination of CF to DCM (26). This was followed by another study showing the 
involvement of another Dehalobacter sp. that fermented DCM to acetate (27). A recent 
report by Lee et. al (24) demonstrated the complete dechlorination of up to 40 mg/L CF 
by Dehalobacter lineages; Dehalobacter sp. were responsible for both reductive 
dechlorination of CF to DCM, followed by fermentation of DCM to acetate, CO2 and H2.  
A signficant disadvantage of the co-culture developed by Lee et al. (24), however, was 
the fact that accumulation of hydrogen inhibited DCM fermentation.  Further studies are 
required to develop a microbial consortium consisting of CF dechlorinators and DCM 
fermenters that can effectively detoxify high concentrations of CF, as occurs in the 
vicinity of DNAPLs, on the order of hundreds of micrograms per liter.    
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 Unlike CF, hydrogen did not inhibit DCM fermentation, at least at the highest 
level tested in this research (6% of the headspace).  The lack of inhibition is consistent 
with predictions based on Gibbs free energy change for each of the fermentation 
reactions that may be involved in the pathway (equations 1.1-1.3), i.e., the free energy 
change is negative at standard conditions, which presumes 1 atm concentration of 
hydrogen.  What is more surprising is the fact that Lee et al. (24) reported inhibition of 
DCM fermentation by hydrogen at 20% of the headspace volume; their observation is not 
in agreement with thermodynamic expectations.  Nevertheless, additional testing of the 
Clemson DCM culture at higher hydrogen concentrations will help establish a potential 
limit for inhibition.   
 Photomicrographs of the enrichment culture showed a diversity of microbes; it 
included gram positive rods and cocci, along with gram negative rods and filaments, 
enmeshed in iron sulfide particles in the medium. Growth of colonies from an aliquot of 
this culture in agar dilution series, followed by the transfer of individual colonies to 
liquid medium allowed narrowing down the microbial community to DCM degraders and 
a few contaminants. This was represented by a smaller range of morphology, mainly 
gram positive thick rods, thin rods and filaments. These results indicate that some of the 
rods observed may be Dehalobacterium, which are gram positive short rods (18, 20).  It 
should be possible to further purify the culture by successive dilutions in agar, followed 
by 16S rDNA sequencing to establish the identity of the isolate. 
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CHAPTER FIVE: CONCLUSIONS AND RECOMMENDATIONS 
 Based on the experiments performed with the DHM-1 enrichment culture, the 
following conclusions were reached: 
i. In the presence of CS and B12, the DHM-1 enrichment culture completely 
biodegraded 26 mg/L of CFC-11.  On a molar basis, less than 6% of the CFC-11 
consumed accumulated as HCFC-21 and HCFC-31.  The balance of the CFC-11 
was defluorinated, based on a stoichiometric release of fluoride.  These results 
confirm the ability of the DHM-1 enrichment culture to convert high 
concentrations of CFC-11 into nonhazardous products.  This result is consistent 
with previous research that demonstrated the same ability with CT and CF.   
ii. The DHM-1 enrichment culture was able to biodegrade ~500 mg/L of CF when 
the inoculum dose was as low as 10
-8
 percent by volume.  Using such a low 
inoculum volume reduced the maximum rate of CF biodegradation, although the 
time required to consume the CF was increased by only a few days.  These results 
demonstrated the potential to use the DHM-1 enrichment culture for 
bioaugmentation of source areas, since the dose required is minor relative to the 
volume of groundwater that could be treated.   
 
 Based on the experiments performed with the DCM enrichment culture, the 
following conclusions were reached: 
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i. The enrichment culture is able to biodegrade at least 740 mg/L of DCM (the 
highest concentration reported thus far), indicating its potential usefulness in 
treating groundwater located near source areas containing DNAPL.  
ii. DCM biodegradation was not inhibited by the addition of H2, at least up to H2 
levels of ~6% headspace volume.  This result was consistent with predictions 
based on Gibbs free energy changes for DCM fermentation to formate and 
formate disproportionation to H2, as well as direct fermentation of DCM to 
acetate and H2.   
iii. Addition of 1 mg/L of CF to the DCM enrichment culture completely inhibited its 
biodegradation of DCM.  CF concentrations of 0.1 to 0.8 mg/L slowed the rate of 
DCM utilization but did not prevent it.  Preliminary efforts suggest it will be 
possible to gradually acclimate the DCM enrichment culture to CF concentrations 
above 1 mg/L.   
iv. Growth of the DCM enrichment culture in agar, followed by transfer of individual 
colonies to liquid medium, did not yield a pure culture.  However, the process did 
facilitate further enrichment that allowed for better microscopic observation.  The 
dominant morphology consists of gram positive thick rods, thin rods and 
filaments. The rods are similar in appearance and gram stain to Dehalobacterium, 





The following recommendations are offered: 
i. Due to the high unit cost of B12, selection of a cost-effective dose of B12 is needed 
when it is used as an amendment to facilitate the bioremediation of halomethanes. 
Further research is required to define the Michaelis-Menten relationship between 
B12 dosage and the rate of CFC-11 biodegradation, as has been done previously 
with CF.  
ii. Further studies should be conducted to determine if the Clemson enrichment 
culture can biodegrade DCM at levels greater 740 mg/L.  This was the highest 
level tested and it turned out not to be inhibitory, although it did present a greater 
challenge in terms of avoiding a sharp drop in pH or too high an accumulation of 
salts from neutralization.   
iii. On-going studies to evaluate acclimation of the DCM enrichment culture to CF 
should be continued.  If acclimation is accomplished, the potential exists to 
develop a co-culture that ferments DCM to organic acids and H2, which could be 
used as the electron donor for organohalide respiration of CF to DCM.   
iv. Now that a procedure has been demonstrated to grow the DCM enrichment 
culture in agar dilutions, further effort is warranted to obtain a pure culture by 
making additional transfers.  It would then be possible to identify the microbe that 







Table 2.1: Experimental design for Set I, F
-
 mass balance from CFC-11 
Treatment
a 





A:  DHM-1 with CFC-11 4 26 0 
B:  DHM-1 with CFC-11 + CF 4 26 500 
C:  DHM-1 with CF 2 0 500 
a 
Microcosms were prepared in quadruplicate in 160 mL  bottles with 100 mL liquid; 
each bottle had 93 mL MSM-1, 5 mL DHM-1 inoculum, 0.27 mL CS stock solution (5 
mM) and 1.84 mL B12 stock solution (7.38 mM). 
b
 Obtained by adding 5.6 µL neat compound. 
c




Table 2.2: Experimental design for Sets II and III, F
- 



















A:  DHM-1-B12-CS 5 972 136 26 92.9 
B:  DHM-1-CS 5 972 0 26 94.7 
C:  B12 0 0 136 26 98.2 
D:  None 0 0 0 26 100.0 
a
 Microcosms were prepared in triplicate in 160 mL bottles with 100 mL liquid. 
b
 Obtained by adding 0.27 mL of 5 mM CS stock solution.  
c
 Obtained by adding 1.84 mL of 7.38 mM vitamin B12 stock solution.  
d
 Obtained by adding 5.6 µL neat compound for Set II; 20 µL of CFC-11 in methanol 
stock solution (0.415 g CFC-11/g stock) for Set III. 
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A 5.0 1:1 5.000 972 136 500 90.4 
B 1.0E-02 1:10 0.100 972 136 500 95.3 
C 1.0E-04 1:103 0.100 972 136 500 95.3 
D 1.0E-06 1:103 0.001 972 136 500 95.4 
E 1.0E-08 1:105
 
0.001 972 136 500 95.4 
F 0 0 0 972 136 500 95.4 
G 0 0 0 0 136 500 98.1 
H 0 0 0 0 0 500 100.0 
I 0 0 0 972 0 500 97.3 
WC 0 0 0 0 0 500 100.0 
a
 Microcosms were prepared in triplicate in 160 mL  bottles with 100 mL liquid. 
b
 DHM-1 inoculum was serially diluted before addition to microcosms (v/v).  
c
 Obtained by adding 2.7 mL of 0.5 mM filter-sterilized CS stock solution. 
d
 Obtained by adding 1.84 mL of 7.38 mM filter-sterilized vitamin B12 stock solution.
 
e
























CF + DCM 1  173  44 0 
H2 + DCM 0 173  44 4 to 60 
DCM 0 173  44 0 
H2  0 0 44 4 to 60 
a
 Microcosms were prepared in duplicate in 70 mL bottles with 44 mL of liquid. 
b
 Obtained by addition of 6 µL of CF-saturated water. 
c
 Obtained by addition of 6 µL of neat compound. 
d



















A 0 173 44 
B 0.1 173 44 
C 0.2 173 44 
D 0.4 173 44 
E 0.6 173 44 
F 0.8 173 44 
WC
d




 Microcosms were prepared in triplicate in 70 mL serum bottles with 44 mL of liquid.  
b
 Obtained by addition of 36-284 µL of 1:50 diluted CF-saturated water. 
c
 Obtained by addition of 6 µL of neat compound. 
d
 Water controls had 44 mL of autoclaved DDI instead of DCM culture. 
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I-A DHM-1 + CS + B12 0 60.1 ± 0.44
a 
54.0 ± 1.8 4.5 ± 0.1 0.20 ± 0.12 97.4 ± 3.8
 
I-B DHM-1 + CS + B12 500 60.9 ± 0.00 55.9 ± 1.6 2.8 ± 0.1 2.15 ± 0.28 99.9 ± 3.1 
II-A DHM-1 + CS + B12 0 60.9 ± 0.00 63.9 ± 5.7 2.2 ± 0.1 0.34 ± 0.10 102.2 ± 8.8 
        
II-B DHM-1 + CS 0 -
c
 - - - - 
II-C MSM-1 + B12 0 29.19 ± 2.14 21.77 ± 2.28 0.33 ± 0.04 0.04 ± 0.02 75.4 ± 2.2 
II-D MSM-1, no B12 0 3.44 ± 2.77 0 0.04 ± 0.03 0.04 ± 0.03 0 
III-A DHM-1 + CS + B12 0 65.2 ± 2.05 57.5 ± 1.6 2.3 ± 0.2 0.13 ± 0.03 91.8 ± 5.3 
III-B DHM-1 + CS  0 1.8 ± 1.2 0 0.9 ± 0.1 0.09 ± 0.04 0 
III-C MSM-1 + B12 0 25.0 ± 0.6 13.5 ± 2.5 0.7 ± 0.3 0.08 ± 0.07 55.6 ± 8.5 
III-D MSM-1, no B12 0 0 0.2 ± 0.3 0.1 ± 0.03 0.40 ± 0.28 0 
        
 
       
a  
± = Standard deviation. 
b
 (µmol of F
-
 released/µmol of CFC-11 consumed/bottle)*100 
c





Table 3.2: Summary of CF degradation rates, DHM-1 inoculum dose study 
Treatment
a
 % Inoculum (v/v) 








A 5.0 30.1 ± 1.5 3 
B 1.0E-02 22.7 ± 0.6 4 
C 1.0E-04 20.2 ± 1.0 4 
D 1.0E-06 17.3 ± 0.9 4 
E 1.0E-08 17.0 ± 0.8 4 
F 0 2.3 ± 0.3 5 
G 0 1.2 ± 0.3 5 
H 0 0 5 
I 0 0.6 ± 0.2 5 
WC 0 0 5 
a
 Average of triplicates in 160 mL serum bottles with 100 mL liquid. 
b
 Slopes and standard errors obtained from regression analysis. Slopes are statistically 
























Figure 1.2: Pathway proposed by Mägli et al. (38) for anaerobic biodegradation of DCM 












Figure 3.1: Average of Set I-A treatment containing DHM-1, CS, B12 and CFC-11. Error 
bars represent the standard deviation of quadruplicate bottles. Arrows represent the 


























Figure 3.2: Average of Set I-Btreatment containing DHM-1, CS, B12, CFC-11 and CF; a) 
CFC-11 degradation and b) CF degradation. Error bars represent the standard deviation 
of quadruplicate bottles. Arrows represent the addition of corn syrup.  Fluoride was 
measured at the start and end of the incubation period. 
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Figure 3.3: Average of Set II microcosms.  Live bottles contained DHM-1, CS, B12 and 
CFC-11 (treatment A). The control (CFC-11-MC) contained only MSM and CFC-11 
(treatment D).  CHCl2F, CH2ClF, CH4, and fluoride are for the live treatment only.  Error 
bars show standard deviations of triplicate bottles. Arrow represents the addition of corn 










Figure 3.4: Average of Set III treatments; a) CFC-11 in all treatments and b) volatile 
compounds other than CFC-11 in the live treatment with DHM-1, B12, and CS added.   
Fluoride was measured at the start and end of the incubation period.  Error bars show 






Figure 3.5: CF degradation with different inoculum doses of DHM-1. Treatments A 
through E contained DHM-1, CS and B12. Treatments F through I were sterile. Water 
controls were sterile with no CS or B12 added. Error bars show standard deviation of 











Figure 3.6: DCM enrichment culture in 160 mL serum bottles degrading increasing 








Figure 3.7: Cumulative DCM and H2 consumption in enrichment cultures; a) DCM 
consumption in treatments containing only DCM (-CF, -H2); with DCM and CF (+CF); 
with DCM and H2 (+H2),  b) H2 consumption in treatments containing only H2 (-DCM); 
with DCM and H2 (+DCM) and c) methane formation in all treatments.  Figure shows the 







Figure 3.8: CF inhibition of DCM degradation; a) DCM consumption in microcosms 
containing different concentrations of CF and b) CF levels in microcosms set up to assess 





Figure 3.9: DCM levels in representative Balch tubes observed in terms of peak area 












Figure 3.10: Photomicrographs (1000X) for a) phase contrast of a sample grown from a 
single colony in MSM-3 in a Balch tube; and b) a gram stain for a sample from a 




















Appendix A: GC response factors and standard curves 
Table A.1: GC TCD response factors for hydrogen at 23°C 







1.2 1.02E-04 0.9999 
Hydrogen
b
 1.2 5.093E-05 0.9996 
a 
Based on liquid volume of 100 mL and gas volume of 60 mL in a 160 mL serum bottle. 
b 
Based on liquid volume of 44 mL and gas volume of 26 mL in a 70 mL serum bottle. 
 
 
Table A.2: GC FID response factors for volatile organic compounds at 23°C 
a 




(µmol/bottle to mg/L) 
Methane 0.5 3.981E-06 0.0002 
CCl3F 5.8 1.130E-05 0.4188 
CF 7.1 4.571E-05 1.1052 
CH2ClF 1.9 1.095E-04 0.5830 
CHCl2F 4.2 7.776E-05 0.9109 
CM 1.2 1.221E-05 0.4248 
CS2 5.4 7.223E-04 0.5150 
DCM 4.6 5.315E-05 0.8101 
a 
















(µmol/bottle to mg/L) 
Methane 0.5 9.7480E-07 0.9999 0.0005 
CF 7.1 1.461E-05 0.9918 2.5147 
CM 1.2 5.279E-06 0.9999 0.9679 
DCM 4.6 1.977E-05 0.9957 1.8425 
a 


















Figure A.1: GC TCD response curves for hydrogen in a) 100 mL liquid phase and 60 mL 







Figure A.2: GC FID response curves for a) CFC-11 and b) methane, in bottles with 44 







Figure A.3: GC FID response curves for a) CF, b) DCM and c) CM, in bottles with 44 






Table A.4: Standard free energy of formation values (ΔGf, aq) 
Compound ΔGf, aq (kJ/mol) Reference 
DCM -67.03 A and B 
Water -237.17 C 
CO2 -394.4 C 
Proton -39.83 C 
Hydrogen 0 C 
Formate -351.04 C 
Acetate -369.41 C 
Chloride -131.3 D 
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and its utilization as a growth substrate under methanogenic conditions. Appl.  
Environ. Microbiol. 57:2847-2857. 
C: Madigan, M.T., Martinko, J.M., Stahl, D. and Clark, D.P. Brock Biology of 
Microorganisms, 12th edition. Prentice Hall, Inc., New Jersey. 
D: Stumm, W. and Morgan, J.J. 1996. Aquatic Chemistry, Chemical Equilibria and 








Appendix B.1: Media preparation for DHM-1 culture (MSM-1) 
Solutions needed for media: 
-Trace Metal Solution 
In a 1 L volumetric flask, add 1500 mg of FeCl2∙4H2O, 190 mg of CoCl2∙6H2O, 
100 mg of MnCl2∙4H2O, 70 mg of ZnCl2, 6 mg of H3BO4, 36 mg of 
Na2MoO4∙2H2O, 24 mg of NiCl2∙6H2O, and 2 mg of CuCl2∙2H2O. Fill to 1 L with 
DDI water. 
-Selenite Solution 
In a 1 L volumetric flask, add 3 mg of Na2SeO3 and 5 mg of NaHCO3. Fill to 1 L 
with DDI water. 
-Ferrous Solution 
In a 1 L volumetric flask, add 3 mg of FeCl2·4H2O and 5 mg of NaHCO3. Fill to 1 
L with DDI water. 
-Redox Solution 
In a 100 mL volumetric flask, add 0.1 g resazurin.  Fill to 100 mL with DDI 
water. 
-Yeast Extract Solution 
In a 100 mL volumetric flask, add 5 g yeast extract. Fill to 100 mL with DDI 
water. 
Media Preparation: 
In a 1 L volumetric flask, add 300 mg of NH4Cl, 300 mg of KCl, 150 mg of CaCl2·2H2O, 
400 mg of MgCl2·6H2O, 410 mg of K2HPO4, 4 g of NaHCO3, 1 mL of trace metal 
solution, 1 mL of selenite solution, 1 mL of ferrous solution, 1 mL of redox solution, and 
1 mL of sterilized yeast extract solution. Fill to 1 L with autoclaved DDI water. Transfer 
to 1 L bottle and purge with 30% CO2/70% N2 for a few minutes until complete 
dissolution of mineral salts. Add 120 mg of Na2S·9H2O crystals that have been rinsed 
and blotted dry with Kimwipes in a completely anaerobic chamber and allow solution to 






Appendix B.2: Media preparation for DCM culture (MSM-2) 
Solutions needed for media: 
- Phosphate buffer 
In a 100 mL volumetric flask add 5.25 g K2HPO4. Fill to 100 mL with DDI water. 
- Salt solution 
In a 100 mL volumetric flask add 5.35 g NH4Cl, 0.46976 g CaCl2:2H2O, and 
0.17787 g FeCl2:H2O. Fill to 100 mL with DDI water. 
- Trace metals solution 
In a 100 mL volumetric flask add 0.03 g H3BO3, 0.0211 g ZnSO4:7H2O, 0.075 g 
NiCl2:6H2O, 0.1 g MnCl2:4H2O, 0.01 g CuCl2:2H2O, 0.15 g CoCl2:6H2O, 0.002 g 
Na2SeO3, 0.01 g Al2(SO4)3:16H2O, and 1 mL concentrated HCl. Fill to 100 mL 
with DDI water. 
- Magnesium sulfate solution 
In a 100 mL volumetric flask add 6.25 g MgSO4:7H2O. Fill to 100 mL with DDI 
water. 
- Bicarbonate solution 
In a 500 mL volumetric flask add 8.0 g NaHCO3. Fill to 500 mL with DDI water. 
- Redox solution 
In a 10 mL volumetric flask add 0.01 g resazurin. Fill to 10 mL with DDI water. 
- Ferrous sulfide solution 
To be added directly to autoclaved media in glove box after adding filter-
sterilized solutions.  For 1 L, weigh out 0.24g of Na2S.9H2O and 0.1448g 
FeCl2:H2O based on stock concentrations of 24 g/L and 14.48 g/L, into separate 
vials.  Add the Na2S:9H2O and allow media to clear.  Add the FeCl2:H2O and 
rinse both vials out with the 10 mL of autoclaved DDI water needed to balance 
the solution and add to the media. 
-Yeast extract solution 
In a 100 mL volumetric flask add 0.5 g yeast extract. Fill to 100 mL with DDI 
water. 
Media Preparation: 
 In a 1 L bottle add 10 mL phosphate solution, 10 mL salt solution, 2 mL trace 
metals solution, 2 mL magnesium sulfate solution, 1 mL redox solution, and 905 mL DDI 
water.  Autoclave this solution, and then add 50 mL filter sterilized bicarbonate solution 
61 
























Appendix B.3: Media preparation for microbial isolation (MSM-3) 
Solutions needed for media: 
- Magnesium sulfate solution 
In a 100 mL volumetric flask add 12 g K2HPO4. Fill to 100 mL with DDI water. 
- Trace metals solution 
In a 100 mL volumetric flask add 1 mL of 25% HCl, 150 mg FeCl2.4H2O, 19 mg 
CoCl2.6H2O, 10 mg MnCl2.4H2O. 7 mg ZnCl2, 0.6 mg H3BO3, 3.6 mg 
Na2MoO4.2H2O, 2.4 mg NiCl2.6H2O, 0.2 mg CuCl2.2H2O, 0.4 g EDTA and 0.3 
mg Na2SeO3. Fill to 100 mL with DDI water. 
- Vitamin solution 
In a 100 mL volumetric flask add 4 mg biotin, 4 mg folic acid, 20 mg pyridoxine 
hydrochloride, 10 mg thiamine hydrochloride, 10 mg riboflavin, 10 mg nicotinic 
acid, 10 mg DL-calcium pantothenate, 5.2 mg vitamin B12, 10 mg p- 
aminobenzoic acid and 10 mg lipoic acid. Fill to 100 mL with DDI water. 
 
Media Preparation: 
 In a 1 L bottle add 0.5 g NH4Cl, 1.48 g KH2PO4, 3 g NaHCO3, 1.15 mL of 1 g/L 
resazurin stock solution. Autoclave this solution, and then add 50 mg of yeast extract,  
filter sterilized 1mL MgSO4 solution, 1 mL trace metals solution, 1 mL vitamin solution 












Appendix C: IC response factors and standard curves 
Table C.1: IC response factors for Fluoride (Retention time of 4.4 minutes) 
Date 




7-Sep-2012 418.22 0.9921 
16-Sep-2012 431.45 0.9913 
3-Oct-2012 427.12 0.9933 
8-Oct-2012 397.50 0.9951 
15-Oct-2012 419.74 0.9911 
2-Nov-2012 428.12 0.9920 
12-Nov-2012 448.94 0.9961 
21-Nov-2012 426.07 0.9988 
30-Nov-2012 451.63 0.9985 
19-Dec-2012 458.67 0.9906 











Figure C.1: Summary of fluoride response factors taken at different time intervals. 
 
Figure C.2: IC response curves for fluoride obtained on 4/18/2013. 
y = 429.19870x 

















Appendix D: Fluoride standard addition analysis 
Table D.1: Standard addition analysis for CFC-11 experimental bottles 
Sample IC Vial 
Area 
(µS/min) 




DHM+CS+B12 #1 (2.5 mL)
b
 0.5106 219 
DHM+CS+B12 #2 (2.5 mL)
 
 0.4943 212 
DHM+CS+B12 #3 (2.5 mL)
 
 0.5226 224 
    
B 
DHM+CS+B12 #1 (2.5 mL) + 1,000 µg/L 
std (2.5 mL) 
0.5038 216 
DHM+CS+B12 #2 (2.5 mL) + 1,000 µg/L 
std (2.5 mL) 
0.4613 198 
DHM+CS+B12 #3 (2.5 mL) + 1,000 µg/L 
std (2.5 mL) 
0.5118 220 
    
C 
1,000 µg/L std (2.5 mL)+ DDI #1  
(2.5 mL) 
0.2336 100 
1,000 µg/L std (2.5 mL)+ DDI #2  
(2.5 mL) 
0.2379 102 
1,000 µg/L std (2.5 mL)+ DDI #3  
(2.5 mL) 
0.2411 103 
Average   102 








Sample #2 90.2% 
Sample #3 105.5% 
Average   100.1% 
a
 All the contents added to the IC vial were diluted 1:50 and passed through a 0.2 um 
PTFE filter. 
b
 DHM+CS+B12 represents each of the triplicate bottles containing MSM, CS, B12 and 
26 mg/L of CFC-11. 
c
 Standard recovery of fluoride= ((B-0.5*A)/C )*100; where A=µg/L of fluoride in 
experimental sample; B=µg/L of fluoride with 50% of experimental sample + 50% of 
1000 µg/L standard, C=µg/L of fluoride with 50% of DDI + 50% of 1000 µg/L 
standard. 
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Appendix E.1: Set I CFC-11 treatments 
 
Figure E.1: Average of Set I-C treatments containing DHM-1, CS, B12 and CF. Error 











Appendix E.2: Set II CFC-11 treatments 
 
Figure E.2: Average of Set II-B treatments containing DHM-1, CS and CFC-11. Error 
bars show standard deviations of triplicate bottles. Arrows represent the addition of corn 
syrup to the live treatment.  Fluoride was monitored over time. 
 
Figure E.3: Average of Set II-C treatments containing MSM, B12 and CFC-11. Error bars 
show standard deviations of triplicate bottles. Fluoride was monitored over time. 
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Figure E.4: Average of Set II-D treatments containing only MSM and CFC-11. Error 












Appendix E.3: Set III CFC-11 treatments 
 
Figure E.5: Average of Set III-A treatments containing DHM-1, CS, B12 and CFC-11. 
Error bars show standard deviations of triplicate bottles. Arrows represent the addition of 
corn syrup to the live treatment.  Fluoride monitored at the start and end of the 
incubation. 
 
Figure E.6: Average of Set III-B treatments containing DHM-1, CS and CFC-11. Error 
bars show standard deviations of triplicate bottles. Arrows represent the addition of corn 
syrup to the live treatment.  Fluoride was monitored at the start and end of the incubation. 
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Figure E.7: Average of Set III-C treatments containing MSM, B12 and CFC-11. Error 
bars show standard deviations of triplicate bottles. Fluoride was monitored at the start and 
end of the incubation period. 
 
Figure E.8: Average of Set III-D treatments containing only DHM-1and CFC-11. Error 
bars show standard deviations of triplicate bottles. Fluoride was monitored at the start and 
end of the incubation period. 
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Appendix E.4: CF degradation rates by regression analysis 
 
Figure E.9: Regression analysis for 1E-08 % inoculum dose treatment using four time 







y = -17.021x + 440.44 
















Appendix F: Effect of CF and H2 on DCM degradation 
 
Figure F.1: Average DCM and CF levels in treatments provided with 173 mg/L DCM 
and 1 mg/L CF. Error bars represent the standard deviation of duplicates. 
 
Figure F.2: Average DCM levels in treatments provided with 173 mg/L DCM. No CF 
was added to them. Error bars represent the standard deviation of duplicate bottles. 
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Figure F.3: Average DCM levels in treatments provided with173 mg/L DCM and 4-60 
µmol/bottle of hydrogen gas. Error bars represent the standard deviation of duplicate 
bottles. 
 
Figure F.4: Average hydrogen and methane levels in treatments provided with 4-60 
µmol/bottle of hydrogen gas. Error bars represent the standard deviation of duplicate 
bottles. 
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Figure G.1: CF inhibition of DCM degradation; a) DCM consumption in treatments 
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